Navigation Links
HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry
Date:3/11/2008

FREMONT, Calif., March 11 /PRNewswire/ -- HOYA ConBio(TM), a global leader in dental and aesthetic lasers, today announced that dentists who purchase DioDent(TM) Micro 980 soft tissue lasers will receive a tuition-free introductory laser certification course with Advanced Laser Training, a company dedicated to dental laser education. The partnership is the latest milestone in HOYA ConBio's corporate commitment to comprehensive laser dentistry education.

"We fully recognize that training is an integral element to ensure success in laser dentistry and are excited to partner with Advanced Laser Training to provide initial training to dentists who want to step up and enhance their practice with laser technology," said Timothy S. Gehlmann, President & CEO, HOYA ConBio. "This new program is intended to provide dentists with an easy, effortless way to fully understand and utilize lasers for optimum patient outcomes and practice growth."

Advanced Laser Training offers an extensive array of basic and advanced laser certification courses year-round throughout the U.S. According to Chris Owens, DDS, owner of Advanced Laser Training, the strategic partnership with HOYA ConBio supports the mission of his organization.

"Proper and thorough training is essential to building confidence and expertise in laser dentistry procedures," Dr. Owens said. "Our courses are designed to provide in-depth skill-based knowledge that will enable dentists to incorporate lasers effectively and profitably into their practice."

The introductory Soft Tissue Laser Certification course covers laser physics, safety and tissue interaction including specific techniques for laser periodontal therapy. Course graduates will have hands-on training in the set- up, operation and maintenance of the DioDent Micro 980 laser. They will also be able to diagnose and perform a variety of soft tissue laser procedures, determine which patients are best candidates for laser therapy and an
'/>"/>

SOURCE HOYA ConBio
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. HOYA ConBio Announces Educational Agreement With LVI Global
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. MDS to Present at Thomas Weisel Partners Healthcare Conference
8. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
9. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...ct. 1 Sunnylife Global, Inc.,(Pink Sheets: SNYL) ...ns,and financial public relations services. At a ... quality,healthcare management in China and build ...We are thrilled to have been retained to represent...
...J., Oct. 1 Wedgewood Pharmacy and Midwest,Veterin...gency agreement,through which Midwest will represe...000 veterinary clinics in 27 states. The relations...gewood,s compounding services will,be offered to v...
...Oct. 1 In honor of Hispanic Heritage,Month in the...speakers,worldwide, the International Hyperhidrosi...version of its popular patient education brochure.... speak at,the 21st World Congress of Dermatology o...
...chultz Investigates the "Social Brain" in Children...ILADELPHIA, Oct. 1 An internationally,prominent e...ts with,autism, Robert T. Schultz, Ph.D., is joini... Most recently the director of the Yale Developmen...
..., Oct. 1 Merlyn Medical has announced,receipt of ...id warmer that,requires neither battery nor electr...2007 EMS Expo in Orlando, FL, October 11-13 and th...ation vehicles, field use, rescue, or other applic...
...est Distributors and Pharmacy Chains to Carry RESP...evice, NEW YORK and MAROOCHYDORE, Australia, Oct....hat its RESPeRATE(R) hypertension,treatment device... marketing and distribution partner, High Tech,Hea...
Other Medicine News:Health News:Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 3Health News:In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 3Health News:Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 3Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 4
(Date:12/4/2009)WASHINGTON, Dec. 4 A simple, inexpensive computer tool that measures volume changes in the size of suspicious nodules in the lungs picked up by a CT scanner can rule out non-cancerous ones with almos
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Amber Pharmacy Earns Accreditation From ACHC 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Knee Splints Multi Compartment Technology Speeds Rehabilitation from Injuries 6170 1Knee Splints Multi Compartment Technology Speeds Rehabilitation from Injuries 6170 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 1eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 3Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 1Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 2Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 3Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 4Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 5
... ,Moderate Complexity, Categorization Highlights G...se-of-Use, SUNNYVALE, Calif., Nov. 4 Cepheid (Na...dministration (FDA) categorized,Cepheid,s Xpert(TM...plexity" under the Clinical Laboratory Improvement...n-demand detection of Methicillin-resistant,Staphy...
...rdAF Registry Baseline Data and New Data from the ...udy, PARIS, Nov. 4 , Live Webcast Media Brief...08 - 14.00-15.00am CET, Background:, -- AF is a ...creased morbidity and mortality, -- There is ...rdAF, which takes a closer look at disease cha...
Other Medicine Technology:Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 4Tackling Atrial Fibrillation and Associated Cardiovascular Risk 2
Gibco Penicillin-Streptomycin liquid
Gibco Antibiotic-Antimycotic (100X), liquid
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
Medicine Products: